Vitro Diagnostics Inc (fka VODG)

[aboveandbeyond]

Quote from the letter: "Revenues derived from our cell lines increased by 67% during 2015 as compared to 2014. Also, sales of our cell culture media expanded by 100% in 2015 compared to 2014 due to increased demand for our research products"

It does note later that overall YOY revenues decreased 30% due largely to European conditions. However the focus on TBI treatments and the items mentioned above are likely the keys to seeing overall increased revenues in 2016.

I firmly believe that with the capital structure being what it is the focus in the TBI area will push this stock to previously unseen levels.